Similar results were observed when all three LRRK2 Asian risk variant groups were combined into one LRRK2 group and comparing with non-carriers (data not shown), with no significant differences in motor features, MDS-UPDRS parts II and III scores, H&Y staging, CISI-PD scores, and motor-predominance phenotype. The gene discussed is LRRK2; the disease is Parkinson disease.